NVS - Novartis AG

NYSE - NYSE Delayed price. Currency in USD
Currency in USD

Valuation measures4

Market cap (intra-day) 208.29B
Enterprise value 225.24B
Trailing P/E 30.48
Forward P/E 14.93
PEG ratio (5-yr expected) 4.08
Price/sales (ttm)4.12
Price/book (mrq)4.00
Enterprise value/revenue 4.31
Enterprise value/EBITDA 13.20

Trading information

Stock price history

Beta (5Y monthly) 0.47
52-week change 311.28%
S&P500 52-week change 32.92%
52-week high 3105.56
52-week low 374.09
50-day moving average 398.41
200-day moving average 388.00

Share statistics

Avg vol (3-month) 32.21M
Avg vol (10-day) 32.51M
Shares outstanding 52.12B
Implied shares outstanding 6N/A
Float 820.06B
% held by insiders 10.01%
% held by institutions 18.25%
Shares short (14 May 2023) 44.28M
Short ratio (14 May 2023) 42.38
Short % of float (14 May 2023) 4N/A
Short % of shares outstanding (14 May 2023) 40.20%
Shares short (prior month 13 Apr 2023) 45.5M

Dividends & splits

Forward annual dividend rate 43.5
Forward annual dividend yield 43.60%
Trailing annual dividend rate 33.46
Trailing annual dividend yield 33.50%
5-year average dividend yield 43.56
Payout ratio 4107.32%
Dividend date 319 Mar 2023
Ex-dividend date 408 Mar 2023
Last split factor 21116:1000
Last split date 308 Apr 2019

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)30 Mar 2023


Profit margin 13.45%
Operating margin (ttm)25.47%

Management effectiveness

Return on assets (ttm)7.00%
Return on equity (ttm)12.35%

Income statement

Revenue (ttm)52.22B
Revenue per share (ttm)2.43
Quarterly revenue growth (yoy)3.10%
Gross profit (ttm)36.74B
Net income avi to common (ttm)7.03B
Diluted EPS (ttm)3.32
Quarterly earnings growth (yoy)3.20%

Balance sheet

Total cash (mrq)12.19B
Total cash per share (mrq)0.58
Total debt (mrq)29.2B
Total debt/equity (mrq)56.01
Current ratio (mrq)1.05
Book value per share (mrq)2.48

Cash flow statement

Operating cash flow (ttm)15.54B
Levered free cash flow (ttm)11.48B